Higher Cost Compared to oral supplements, injections are generally more expensive over time
Safety data from trials In a paper summarizing 6 randomized, double-blind, placebo-controlled human trials, AOD 9604 did not significantly affect IGF-1 levels, did not impair glucose tolerance, and no serious adverse events (SAEs) were attributed to AOD 9604
Results: Berberine reduced renal injury in STZ-induced DN rat model, as evidenced by the decrease in fasting blood glucose, ratio of kidney weight to body weight, 24-h urinary protein, serum creatinine, and blood urine nitrogen
PlexusDx compounded semaglutide is $189/mo month-to-month, or from $149/mo on the 6-month plan and compounded tirzepatide at $289 per month through licensed 503A pharmacies, with no prior authorization requirements
Evidence Boundary Most studied route in the Phase 2 program, but the OPTIONS trial missed its primary weight-loss endpoint and development was terminated in 2007
At Real Peptides, we emphasize small-batch synthesis and exact amino-acid sequencing to ensure the highest purity